I

Ind-Swift Ltd

INDSWFTLTD NSE

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ind-Swift Ltd insights

29 extracted metrics + investor summaries across FY14–FY25.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

1
  • Company has delivered good profit growth of 18.2% CAGR over last 5 years

Weaknesses

4
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 9.35% over past five years.
  • Contingent liabilities of Rs.72.4 Cr.
  • Earnings include an other income of Rs.328 Cr.

Growth Rate

Revenue Growth
3.00% →
Net Income Growth
132.00% →
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Results

  Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Sales
106
95
104
107
106
149
116
103
135
114
136
120
145
Expenses
96
90
93
89
98
130
105
98
121
111
122
112
148
Operating Profit
10
5
11
18
8
18
11
4
15
3
14
8
-3
OPM %
9%
5%
11%
17%
8%
12%
10%
4.4%
11%
2.8%
11%
7%
-2%
Other Income
7
2
1
3
67
6
3
3
46
40
5
2
281
Interest
14
15
15
15
14
15
18
15
14
10
10
10
10
Depreciation
8
7
7
7
7
7
7
7
7
5
5
6
7
PBT
-5
-15
-11
-1
53
2
-11
-15
40
28
4
-6
261
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
6%
0%
0%
0%
2%
Net Profit
-5
-15
-11
-1
53
2
-11
-15
38
28
4
-6
257
EPS in Rs
-1.01
-2.85
-1.95
-0.19
9.8
0.44
-1.98
-2.76
6.93
5.21
0.76
-1.01
47.34
Figures in ₹ Crores

Profit & Loss

  Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales
570
417
308
263
270
289
330
356
398
411
502
515
Expenses
602
487
465
328
262
278
306
315
352
369
448
492
Operating Profit
-32
-70
-157
-65
8
11
23
41
45
42
54
23
OPM %
-6%
-17%
-51%
-25%
2.9%
3.7%
7%
12%
11%
10%
11%
4.5%
Other Income
11
2
13
-246
-20
34
22
14
24
72
53
328
Interest
77
40
19
16
7
3
29
52
57
60
63
39
Depreciation
26
39
36
36
35
34
34
33
32
29
27
24
PBT
-124
-147
-200
-363
-53
8
-17
-29
-20
26
16
288
Tax %
-7%
-2%
0%
0%
1%
0%
15%
1%
2%
0%
14%
2%
Net Profit
-116
-145
-200
-364
-54
8
-19
-30
-20
26
14
283
EPS in Rs
-22.97
-28.85
-39.75
-67.21
-9.99
1.51
-3.53
-5.5
-3.69
4.8
2.63
52.3
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

  Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
10
10
10
11
11
11
11
11
11
11
11
11
Reserves
84
-64
-264
-636
-690
-688
-724
-706
-731
-716
-702
-413
Borrowings
1,024
1,054
1,061
1,062
1,055
1,010
1,017
1,023
1,036
993
1,014
874
Other Liabilities
272
228
254
232
237
265
298
344
316
361
331
257
Total Liabilities
1,390
1,228
1,061
669
613
598
602
672
632
649
654
728
Fixed Assets
440
404
374
342
311
291
270
244
236
216
184
243
CWIP
4
4
4
2
0
0
0
13
9
30
51
0
Investments
45
45
45
44
44
41
24
70
64
54
1
6
Other Assets
900
775
638
281
258
267
308
344
323
349
418
480
Total Assets
1,390
1,228
1,061
669
613
598
602
672
632
649
654
728
Figures in ₹ Crores

Cash Flow

  Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating
103
86
-106
7
1
43
35
83
50
73
15
16
Investing
-14
-6
-4
-4
-3
-14
-11
-17
-18
-29
77
3
Financing
-89
-81
110
-11
-4
-13
-26
-54
-45
-47
-42
-13
Net Cash Flow
0
-1
0
-8
-5
16
-3
12
-13
-3
50
6
Free Cash Flow
88
80
-110
2
-5
29
22
63
31
42
-13
-25
CFO/OP
-320
-122
67
-10
17
397
148
202
111
174
28
69
Figures in ₹ Crores

Ratios

  Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
282
425
451
151
113
95
104
111
83
93
111
112
Inventory Days
202
117
151
86
108
112
102
123
120
150
83
150
Days Payable
152
155
290
356
426
454
440
454
353
393
262
143
Cash Conversion Cycle
331
387
311
-119
-206
-246
-234
-220
-149
-150
-68
120
Working Capital Days
94
2
-32
-570
-563
-558
-490
-482
-451
-601
-30
35
ROCE %
-4%
-10%
-20%
-14%
-4%
-4%
2%
8%
11%
8%
13%
12%

Shareholding Pattern

As of Jun 2025
Promoters 55.58%
Public 44.42%
Total 100.00%
  Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Promoters
55.58%
55.58%
55.58%
55.58%
55.58%
55.58%
55.58%
55.58%
55.58%
55.58%
55.58%
55.58%
Public
44.42%
44.40%
44.42%
44.42%
44.42%
44.42%
44.42%
44.42%
44.42%
44.43%
44.42%
44.42%
No. of Shareholders
14,422
14,927
14,785
14,590
13,745
14,219
16,438
17,440
18,028
20,936
21,368
21,588

Documents

Frequently Asked Questions about Ind-Swift Ltd

What does Ind-Swift Ltd do?
Incorporated in 1986, Ind-Swift Ltd deals in manufacturing and exporting of pharmaceutical products
Where is Ind-Swift Ltd (INDSWFTLTD) listed?
Ind-Swift Ltd is listed on the Indian stock exchanges. It is listed on NSE: INDSWFTLTD. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Ind-Swift Ltd belong to?
Ind-Swift Ltd operates in the Healthcare sector within the Pharmaceuticals & Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Ind-Swift Ltd on Tapetide?
On Tapetide, you can view Ind-Swift Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1986, Ind-Swift Ltd deals in manufacturing and exporting of pharmaceutical products

Website indswiftltd.com
Listed 2004-10-18
Face Value ₹ 2

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List